Tyrosine promotes oxidative stress in cerebral cortex of young rats

International Journal of Developmental Neuroscience

Volumn 26, Issue 6, 2008, Pages 551-559

  Sgaravatti, Ângela M ^a   Vargas, Bethânia A ^a   Zandoná, Bernardo R ^a   Deckmann, Kátia B ^a   Rockenbach, Francieli J ^a   Moraes, Tarsila B ^a   Monserrat, José M ^b   Sgarbi, Mirian B ^a   Pederzolli, Carolina D ^a   Wyse, Angela T S ^a   Wannmacher, Clóvis M D ^a   Wajner, Moacir ^a   Dutra Filho, Carlos Severo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

Hypertyrosinemias; Oxidative stress; Rat brain; Tyrosine; Tyrosinemia type II

Indexed keywords

ASCORBIC ACID; CATALASE; DEOXYRIBONUCLEOPROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; TYROSINE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; IN VITRO STUDY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; ASCORBIC ACID; CATALASE; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TYROSINE;

RATTUS; RATTUS NORVEGICUS;

EID: 47149083242     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2008.05.007     Document Type: Article

References (45)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
2. Akerboom T., and Sies H. Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples. Methods Enzymol. 77 (1981) 373-382
3. Ban F., Lundqvist M.J., Boyd R.J., and Eriksson L.A. Theoretical studies of the cross-linking mechanisms between cytosine and tyrosine. J. Am. Chem. Soc. 124 (2002) 2753-2761
4. Dizdaroglu M., Jaruga P., Birincioglu M., and Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 32 (2002) 1102-1115
5. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
6. Evelson P., Travacio M., Repetto M., Escobar J., Llesuy S., and Lissi E.A. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophys. 388 (2001) 261-266
7. Goldsmith L.A., Kang E., Bienfang D.C., Jimbow K., Gerald P., and Baden H.P. Tyrosinemia with plantar and palmarkeratosis and keratitis. J. Pediatr. 83 (1973) 798-805
8. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18 (2001) 685-716
9. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658
10. Halliwell B., and Gutteridge J.M.C. Oxygen radicals and the nervous system. Trends Neurosci. 8 (1985) 22-26
11. Halliwell B., and Gutteridge J.M.C. Antioxidant defences: endogenous and diet derived. In: Halliwell B., and Gutteridge J.M.C. (Eds). Free Radicals in Biology and Medicine (2007), Oxford University Press, Oxford 79-185
12. Halliwell B., and Gutteridge J.M.C. The chemistry of free radicals and related 'reactive species'. In: Halliwell B., and Gutteridge J.M.C. (Eds). Free Radicals in Biology and Medicine (2007), Oxford University Press, Oxford 30-74
13. Hashida K., Sakakura Y., and Makino N. Kinetic studies on the hydrogen peroxide elimination by cultured PC12 cells: rate limitation by glucose-6-phosphate dehydrogenase. Biochim. Biophys. Acta 1572 (2002) 85-90
14. Held P.K. Disorders of tyrosine catabolism. Mol. Genet. Metab. 88 (2006) 103-106
15. Leong S.F., and Clark J.B. Regional enzyme development in rat brain. Enzymes associated with glucose utilization. Biochem. J. 218 (1984) 131-138
16. Lemonnier F., Charpentier C., Odievre M., Larregue M., and Lemonnier A. Tyrosine aminotransferase isoenzyme deficiency. J. Pediatr. 94 (1979) 931-932
17. Light I.J., Sutherland J.M., and Berry H.K. Clinical significance of tyrosinemia of prematurity. Am. J. Dis. Child. 125 (1973) 243
18. Lissi E., Caceres T., and Videla L.A. Visible chemiluminescence from rat homogenates undergoing autoxidation. I. Effect of additives and products accumulation. J. Free Radic. Biol. Med. 2 (1986) 63-69
19. Lissi E., Pascual C., and Del Castillo M.D. Luminol luminescence induced by 2,2′-azo-bis(2-amidinopropane) thermolysis. Free Radic. Res. Commun. 17 (1992) 299-311
20. Lissi E., Salim-Hanna M., Pascual C., and Del Castillo M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic. Biol. Med. 18 (1995) 153-158
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
22. Macsai M.S., Schwartz T.L., Hinkle D., Hummel M.B., Mulhern M.G., and Rootman D. Tyrosinemia type II: nine cases of ocular signs and symptoms. Am. J. Ophthalmol. 132 (2001) 522-527
23. 2 permeation through cytoplasmic and peroxisomal membranes: comparison with experimental data. Biochim. Biophys. Acta 1673 (2004) 149-159
24. Mamunes P., Prince P.E., Thornton N.H., Hunt P.A., and Hitchcock E.S. Intellectual deficits after transient tyrosinemia in the term neonate. Pediatrics 57 (1976) 675
25. Mitchell G.A., Grompe M., Lambert M., and Tanguay R.M. Hypertyrosinemia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 1977-1982
26. Morgane P.J., Mokler D.J., and Galler J.R. Effects of prenatal protein malnutrition on the hippocampal formation. Neurosci. Biobehav. Rev. 26 (2002) 471-483
27. Moriarty-Craige S.E., and Jones D.P. Extracellular thiols and thiol/disulfide redox in metabolism. Annu. Rev. Nutr. 24 (2004) 481-509
28. Morre M.C., Hefti F., and Wurtman R.J. Regional tyrosine levels in rat brain after tyrosine administration. J. Neural Transm. 49 (1980) 45-50
29. Omaye S.T., Turnbull J.D., and Sauberlich H.E. Selected methods for determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol. 62 (1979) 3-11
30. Rabinowitz L.G., Williams R.L., Anderson C.E., Mazur A., and Kaplan P. Painful keratoderma and photophobia: hallmarks of tyrosinemia type II. J. Pediatr. 126 (1995) 266-269
31. Reardon J.T., Cheng Y., and Sancar A. Repair of DNA-protein cross links in mammalian cells. Cell Cycle 13 (2006) 1366-1370
32. Reznick A.Z., and Parker L. Free radicals and antioxidants in muscular neurological diseases and disorders. In: Poli G., Albano E., and Dianzani M.U. (Eds). Free Radicals: From Basic Science to Medicine (1993), Birkäuser Verlag, Basel 425-437
33. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233 (1994) 357-363
34. Rice D.N., Houston I.B., Lyon I.C., Macarthur B.A., Mullins P.R., Veale A.M., and Guthrie R. Transient neonatal tyrosinaemia. J. Inherit. Metab. Dis. 12 (1989) 13
35. Rice M.E., and Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 82 (1998) 1213-1223
36. Scott C.R. The genetic tyrosinemias. Am. J. Med. Genet. C. Semin. Med. Genet. 142 (2006) 121-126
37. Sener R.N. Tyrosinemia-computed tomography, magnetic resonance imaging, diffusion magnetic resonance imaging, and proton spectroscopy findings in the brain. J. Comput. Assist. Tomogr. 29 (2005) 323-325
38. Slotkin T.A., Oliver C.A., and Seidler F.J. Critical periods for the role of oxidative stress in the developmental neurotoxicity of chlorpyrifos and terbutaline, alone or in combination. Brain Res. Dev. Brain Res. 157 (2005) 172-180
39. Uylings H.B. Development of the cerebral cortex in rodents and man. Eur. J. Morphol. 38 (2000) 309-312
40. Valikhani M., Akhyani M., Jafari A.K., Barzegari M., and Toosi S. Oculocutaneous tyrosinaemia or tyrosinaemia type 2: a case report. J. Eur. Acad. Dermatol. Venereol. 20 (2005) 591-594
41. Viglizzo G.M., Occella C., Bleidl D., and Rongioletti F. Richner-Hanhart syndrome (tyrosinemia II): early diagnosis of an incomplete presentation with unusual findings. Pediatr. Dermatol. 23 (2006) 259-261
42. Wajner M., Latini A., Wyse A.T.S., and Dutra-Filho C.S. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J. Inherit. Metab. Dis. 27 (2004) 427-448
43. Wendel A. Glutathione peroxidase. Methods Enzymol. 77 (1981) 325-333
44. Zahler W.L., and Cleland W.W. A specific and sensitive assay for disulfides. J. Biol. Chem. 243 (1968) 716-719
45. Zhitkovich A., and Costa M. A simple, sensitive assay to detect DNA-protein-crosslinks in intact cells and in vivo. Carcinogenesis 13 (1992) 1485-1489